Journal of Exotic Pet Medicine
Volume 17, Issue 3 , Pages 228-229 , July 2008

Ponazuril

  • Mark A. Mitchell, DVM, MS, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Mark A. Mitchell, DVM, MS, PhD, University of Illinois, College of Veterinary Medicine, Department of Veterinary Clinical Medicine, 1008 W. Hazelwood Dr, Urbana, IL 61802

References 

  1. Plumb DC. Ponazuril. In:  Plumb DC editors. Veterinary Drug Handbook. (ed 4). Ames, IA: Blackwell Publishing; 2002;p. 675
  2. Mitchell SM, Zajac AM, Davis WL, et al. The effects of ponazuril on development of apicomplexans in vitro. J Eukaryot Microbiol. 2005;52(3):231–235
  3. Dubey JP, Lindsay DS, Saville WEJA, et al. A review of Sarcocystis neurona and equine protozoal myeloencephalitis. Vet Parasitol. 2001;95:89–131
  4. National Animal Health Monitoring System. Equine Protozoal Myeloencephalitis in the United States. Animal and Plant Health Inspection Service, National Animal Health Monitoring System. United States Department of Agriculture, Ft. Collins, CO, 2001
  5. Marquis (ponazuril) EPM Paste, MSDS Number: R37641, Bayer Animal Healthcare LLC, Shawnee, KS, 2004
  6. Mitchell SM, Zajac AM, Davis WL, et al. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice. J Parasitol. 2004;90(3):639–642
  7. Bogoslavsky BA. The use of ponazuril to treat coccidioisis in eight inland bearded dragons (Pogona vittcieps). In: Proc Assoc Reptil Amphib Vet, New Orleans, LA. 2007;p. 8–9

PII: S1557-5063(08)00072-4

doi: 10.1053/j.jepm.2008.05.013

Journal of Exotic Pet Medicine
Volume 17, Issue 3 , Pages 228-229 , July 2008

Article Tools